Great West Life Assurance CO Xenon Pharmaceuticals Inc. Transaction History
Great West Life Assurance CO
- $57.4 Billion
- Q3 2024
A detailed history of Great West Life Assurance CO transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 15,911 shares of XENE stock, worth $654,737. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,911
Previous 15,911
-0.0%
Holding current value
$654,737
Previous $621,000
1.13%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding XENE
# of Institutions
212Shares Held
70.2MCall Options Held
88.3KPut Options Held
28.8K-
Avoro Capital Advisors LLC New York, NY5.67MShares$233 Million3.36% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.6MShares$189 Million1.77% of portfolio
-
Wellington Management Group LLP Boston, MA3.84MShares$158 Million0.03% of portfolio
-
Braidwell LP Stamford, CT2.71MShares$111 Million3.02% of portfolio
-
Commodore Capital LP New York, NY2.7MShares$111 Million9.03% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.56B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...